Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023

SELL
$7.61 - $9.46 $996 - $1,239
-131 Reduced 0.24%
55,226 $469,000
Q1 2023

May 02, 2023

SELL
$8.83 - $17.61 $71,505 - $142,605
-8,098 Reduced 12.76%
55,357 $505,000
Q4 2022

Feb 09, 2023

BUY
$10.88 - $20.05 $690,390 - $1.27 Million
63,455 New
63,455 $724,000
Q1 2022

May 04, 2022

SELL
$28.19 - $46.6 $273,076 - $451,414
-9,687 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$41.2 - $73.6 $1.04 Million - $1.87 Million
-25,342 Reduced 72.35%
9,687 $441,000
Q3 2021

Nov 02, 2021

SELL
$59.15 - $91.99 $628,941 - $978,129
-10,633 Reduced 23.29%
35,029 $2.22 Million
Q2 2021

Aug 03, 2021

SELL
$63.02 - $95.11 $453,996 - $685,172
-7,204 Reduced 13.63%
45,662 $4.18 Million
Q1 2021

May 04, 2021

BUY
$57.62 - $95.6 $2.4 Million - $3.97 Million
41,578 Added 368.34%
52,866 $3.6 Million
Q4 2020

Feb 01, 2021

BUY
$41.43 - $77.09 $180,676 - $336,189
4,361 Added 62.96%
11,288 $818,000
Q3 2020

Nov 09, 2020

SELL
$30.88 - $37.94 $2,964 - $3,642
-96 Reduced 1.37%
6,927 $263,000
Q2 2020

Aug 07, 2020

BUY
$18.95 - $35.43 $9,228 - $17,254
487 Added 7.45%
7,023 $249,000
Q1 2020

May 04, 2020

SELL
$13.94 - $28.25 $79,318 - $160,742
-5,690 Reduced 46.54%
6,536 $143,000
Q4 2019

Feb 06, 2020

BUY
$19.24 - $28.41 $17,662 - $26,080
918 Added 8.12%
12,226 $264,000
Q4 2019

Feb 04, 2020

BUY
$19.24 - $28.41 $18,547 - $27,387
964 Added 9.32%
11,308 $273,000
Q3 2019

Nov 12, 2019

BUY
$20.03 - $40.08 $186,960 - $374,106
9,334 Added 924.16%
10,344 $234,000
Q4 2018

Feb 05, 2019

SELL
$19.89 - $30.02 $3,818 - $5,763
-192 Reduced 15.97%
1,010 $25,000
Q3 2018

Nov 01, 2018

BUY
$12.1 - $28.85 $14,544 - $34,677
1,202 New
1,202 $35,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.